SNDL
SNDL, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CA
$1.24
−4.62%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 43.64x
- P/S forward
- 0.49x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.42x
- Price / sales
- 0.46x
- Price / cash flow
- 8.31x
Enterprise value
- Enterprise value
- $317.1M
- EV / sales
- 0.48x
- EV / EBITDA
- 10.06x
- EV / EBIT
- -45.95x
- Market cap
- $301.7M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2026